Skip to main content

Leica Biosystems Expands Integration for Cerebro with Novopath Laboratory Information System

VISTA, CALIFORNIA, December 18, 2014 – Leica Biosystems, a global leader in automation and workflow solutions for anatomic pathology, announced today that it will partner with NovoPath™, to seamlessly integrate Cerebro® Specimen Tracking from Leica Biosystems with the NovoPath Anatomic Pathology Laboratory Information System (APLIS). This integration builds on NovoPath’s support of Leica Biosystems labelers, stainers, and other histology equipment to provide an enhanced histology workflow.

Leica Biosystems and NovoPath’s solution will help to reduce human identification errors and identify problems before they lead to any patient safety risks. This integration will enable labs to electronically track samples from specimen receipt, all the way to result delivery. The integration will also provide necessary data to identify bottlenecks and improve workflow efficiency.

“NovoPath is committed to helping anatomic pathology labs increase operational efficiencies and enhance patient safety,” stated Rick Callahan, vice president of sales and marketing for NovoPath.

“Our customers demand that we improve integration of our products with their Laboratory Information Systems. This advancement is critical to the improvement of their overall workflow,” said Puneet Sarin, Leica Biosystems vice president and general manager for the Pathology Imaging Business. “Leica Biosystems is committed to providing turnkey integration. We are delighted to partner with NovoPath.”

About NovoPath
NovoPath, Inc. develops and markets software solutions for the Anatomic Pathology Laboratory market. Since the release of its flagship product in 1999, NovoPath, Inc. has focused exclusively on Anatomic Pathology. NovoPath's mission is to provide unique solutions and services to all aspects of the Anatomic Pathology sector in a way that improves workflow, reduces the probability of human error, ensures results for greater patient safety, protects patient confidentiality, and above all, produces precise and informative diagnostic outcomes. More information is available at

About Leica
Leica Biosystems is a global leader in anatomic pathology solutions and automation, striving to advance cancer diagnostics to improve patients’ lives. Leica Biosystems provides pathologists, histologists and researchers a comprehensive range of products for each step in the pathology process. From specimen preparation and staining to imaging and reporting, our solutions help increase workflow efficiencies meaning patients receive their results sooner. More information is available at


Media Contact(s): Diane Mielnikowski, Director, Global Brand Marketing, +1-847-821-3446